Table 1.

Patient Characteristics

Parameter	Study Population (n=243)	Registry Patients without Echo (n=541)	P
CLINICAL
Age (year)	60 ± 15	61 ± 14	0.86
Male gender	63% (154)	74% (398)	0.004
Atherosclerosis Risk Factors
Diabetes Mellitus	35% (86)	26% (142)	0.009
Hypertension	61% (149)	59% (320)	0.57
Tobacco Use	24% (58)	29% (156)	0.15
Hypercholesterolemia	39% (94)	57% (306)	<0.0001
Prior Myocardial Infarction	44% (108)	50% (269)	0.17
Coronary Revascularization	28% (67)	40% (268)	<0.0001
Percutaneous Intervention	16% (39)	31% (169)	<0.0001
Coronary Artery Bypass Grafting	17% (42)	27% (147)	0.003
Ischemic Cardiomyopathy	63% (154)	74% (401)	0.002
Atrial Fibrillation	19% (45)	14% (74)	0.08
Lifetime History of Prior Cerebrovascular Event
Cerebrovascular Accident (CVA)	9% (22)	7% (37)	0.28
Transient Ischemic Attack (TIA)	7% (16)	4% (22)	0.13
Therapeutic Regimen
Aspirin	58% (140)	69% (371)	0.003
Warfarin	14% (35)	19% (101)	0.14
Thienopryidines	6% (16)	18% (98)	<0.0001
Beta-blocker	51% (125)	71% (386)	< 0.0001
ACE-Inhibitor	46% (111)	63% (343)	<0.0001
Angiotensin Receptor Blocker	6% (15)	13% (70)	0.005
Loop diuretic	31% (76)	45% (244)	0.0003
Spironolactone	11% (26)	18% (96)	0.02
Digoxin	16% (39)	28% (150)	0.0004
Nitroglycerin	28% (150)	18% (44)	0.004
CARDIOVASCULAR MAGNETIC RESONANCE
Left Ventricular Thrombus (DE-CMR)	10% (24)	6% (31)	0.04
Left Ventricular Function and Morphology
Ejection Fraction (%)	28 ± 11	33 ± 10	< 0.0001
Wall motion score	1.7 ± 0.7	1.5 ± 0.7	< 0.0001
% LV with akinesis or dyskinesis*	24% (6 – 41)	24% (6 – 35)	0.054
End-diastolic volume (ml)	210 ± 89	206 ± 85	0.50
End-systolic volume (ml)	156 ± 83	142 ± 79	0.03
Aneurysm present	16% (38)	12% (63)	0.12
Left Ventricular Infarction
Myocardial Infarction (presence)	71% (172)	75% (404)	0.25
Infarct size (% LV)*	10% (0 – 25)	16% (0 – 29)	0.03
% LV with >50% transmural infarction*	0% (0 – 24)	12% (0 – 29)	0.002

Numbers in boldface indicate P values < 0.05

^*Expressed as median (25^th–75^th percentile)